These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Health beliefs and compliance with antipsychotic medication. Budd RJ; Hughes IC; Smith JA Br J Clin Psychol; 1996 Sep; 35(3):393-7. PubMed ID: 8889080 [TBL] [Abstract][Full Text] [Related]
25. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study. Bobes J; Arango C; Garcia-Garcia M; Rejas J; J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779 [TBL] [Abstract][Full Text] [Related]
26. Substance abuse and the management of medication nonadherence in schizophrenia. Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865 [TBL] [Abstract][Full Text] [Related]
27. Early predictors of nonadherence to antipsychotic therapy in first-episode psychosis. Rabinovitch M; Béchard-Evans L; Schmitz N; Joober R; Malla A Can J Psychiatry; 2009 Jan; 54(1):28-35. PubMed ID: 19175977 [TBL] [Abstract][Full Text] [Related]
28. Illness self-management for individuals in acute psychiatric care settings in Japan: cross-cultural adaptation of an American program. Saito M; Edo K; Yamamoto Y; Niwa S; Liberman RP Psychiatr Rehabil J; 2013 Dec; 36(4):272-7. PubMed ID: 24320836 [TBL] [Abstract][Full Text] [Related]
29. Predicting medication-free treatment response in acute psychosis: cross-validation from the Finnish Need-Adapted Project. Bola JR; Lehtinen K; Aaltonen J; Räkköläinen V; Syvälahti E; Lehtinen V J Nerv Ment Dis; 2006 Oct; 194(10):732-9. PubMed ID: 17041284 [TBL] [Abstract][Full Text] [Related]
30. Factors associated with antipsychotic medication adherence in community-based patients with schizophrenia in Hong Kong: a cross sectional study. Bressington D; Mui J; Gray R Int J Ment Health Nurs; 2013 Feb; 22(1):35-46. PubMed ID: 22738372 [TBL] [Abstract][Full Text] [Related]
31. How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia? A cluster-analytical approach. Beck EM; Cavelti M; Wirtz M; Kossowsky J; Vauth R Psychiatry Res; 2011 May; 187(1-2):55-61. PubMed ID: 21074860 [TBL] [Abstract][Full Text] [Related]
32. Nonadherence to antipsychotics: the role of positive attitudes towards positive symptoms. Moritz S; Hünsche A; Lincoln TM Eur Neuropsychopharmacol; 2014 Nov; 24(11):1745-52. PubMed ID: 25444234 [TBL] [Abstract][Full Text] [Related]
33. Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States. Sun SX; Liu GG; Christensen DB; Fu AZ Curr Med Res Opin; 2007 Oct; 23(10):2305-12. PubMed ID: 17697454 [TBL] [Abstract][Full Text] [Related]
34. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication. Rettenbacher MA; Burns T; Kemmler G; Fleischhacker WW Pharmacopsychiatry; 2004 May; 37(3):103-9. PubMed ID: 15138893 [TBL] [Abstract][Full Text] [Related]
35. Lack of insight in schizophrenia: impact on treatment adherence. Buckley PF; Wirshing DA; Bhushan P; Pierre JM; Resnick SA; Wirshing WC CNS Drugs; 2007; 21(2):129-41. PubMed ID: 17284095 [TBL] [Abstract][Full Text] [Related]
36. [Lack of insight in schizophrenia: a review. Part I: theoretical concept, clinical aspects and Amador's model]. Raffard S; Bayard S; Capdevielle D; Garcia F; Boulenger JP; Gely-Nargeot MC Encephale; 2008 Dec; 34(6):597-605. PubMed ID: 19081457 [TBL] [Abstract][Full Text] [Related]
38. Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: data from a randomized double-blind trial. Gharabawi GM; Greenspan A; Rupnow MF; Kosik-Gonzalez C; Bossie CA; Zhu Y; Kalali AH; Awad AG BMC Psychiatry; 2006 Oct; 6():45. PubMed ID: 17054789 [TBL] [Abstract][Full Text] [Related]
39. [Subjective well-being under antipsychotic treatment and its meaning for compliance and course of disease]. Naber D; Lambert M; Karow A Psychiatr Prax; 2004 Nov; 31 Suppl 2():S230-2. PubMed ID: 15586315 [TBL] [Abstract][Full Text] [Related]
40. [What information do patients with schizophrenia have about their illness and treatment?]. Ferreri M; Rouillon F; Nuss P; Bazin N; Farah S; Djaballah K; Gerard D Encephale; 2000; 26(5):30-8. PubMed ID: 11192802 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]